StockData
Soligenix, Inc. logo

Soligenix, Inc. (SNGX) stock

SNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$0.28−0.01 (-2.67%)

Close on Nov 17, 2026Market cap $6.11MP/E –Yield –

Soligenix total assets

Total assets on the balance sheet at the end of each period.

Soligenix's total assets was $10.50M at Jun 30, 2026. For fiscal 2025 it was $9.24M, up 3.0% from the year before. Over ten years it grew 2.3% a year on average. The highest annual figure on record is $26.87M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$9.24M+3.0%
FY2024Dec 31, 2024$8.97M-8.5%
FY2023Dec 31, 2023$9.80M-31.4%
FY2022Dec 31, 2022$14.28M-46.9%
FY2021Dec 31, 2021$26.87M+35.1%
FY2020Dec 31, 2020$19.89M+155.8%
FY2019Dec 31, 2019$7.78M-25.9%
FY2018Dec 31, 2018$10.49M+9.9%
FY2017Dec 31, 2017$9.55M-7.0%
FY2016Dec 31, 2016$10.27M+39.0%
FY2015Dec 31, 2015$7.39M+6.2%
FY2014Dec 31, 2014$6.95M-15.9%
FY2013Dec 31, 2013$8.27M+75.7%
FY2012Dec 31, 2012$4.71M-42.8%
FY2011Dec 31, 2011$8.22M-11.3%
FY2010Dec 31, 2010$9.27M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$10.50M+82.3%
Q1 FY2026Mar 31, 2026$6.92M-10.6%
Q4 FY2025Dec 31, 2025$9.24M+3.0%
Q3 FY2025Sep 30, 2025$11.29M+7.8%
Q2 FY2025Jun 30, 2025$5.76M-41.6%
Q1 FY2025Mar 31, 2025$7.75M-3.9%
Q4 FY2024Dec 31, 2024$8.97M-8.5%
Q3 FY2024Sep 30, 2024$10.48M-7.3%
Q2 FY2024Jun 30, 2024$9.87M-28.6%
Q1 FY2024Mar 31, 2024$8.06M-27.4%
Q4 FY2023Dec 31, 2023$9.80M-31.4%
Q3 FY2023Sep 30, 2023$11.30M-37.0%
Q2 FY2023Jun 30, 2023$13.83M-35.1%
Q1 FY2023Mar 31, 2023$11.10M-53.1%
Q4 FY2022Dec 31, 2022$14.28M-46.9%
Q3 FY2022Sep 30, 2022$17.95M-39.6%
Q2 FY2022Jun 30, 2022$21.31M-28.0%
Q1 FY2022Mar 31, 2022$23.67M-25.0%
Q4 FY2021Dec 31, 2021$26.87M+35.1%
Q3 FY2021Sep 30, 2021$29.72M+124.3%
Q2 FY2021Jun 30, 2021$29.61M+141.5%
Q1 FY2021Mar 31, 2021$31.55M+220.4%
Q4 FY2020Dec 31, 2020$19.89M+155.8%
Q3 FY2020Sep 30, 2020$13.25M+39.2%
Q2 FY2020Jun 30, 2020$12.26M+16.9%
Q1 FY2020Mar 31, 2020$9.85M-25.9%
Q4 FY2019Dec 31, 2019$7.78M+26.4%
Q1 FY2019Mar 31, 2019$9.52M+27.3%
Q4 FY2018Dec 31, 2018$10.49M+9.9%
Q3 FY2018Sep 30, 2018$13.29M+127.1%
Q2 FY2018Jun 30, 2018$6.15M-9.2%
Q1 FY2018Mar 31, 2018$7.48M-11.1%
Q4 FY2017Dec 31, 2017$9.55M-7.0%
Q3 FY2017Sep 30, 2017$5.85M-24.5%
Q2 FY2017Jun 30, 2017$6.77M+25.1%
Q1 FY2017Mar 31, 2017$8.41M+50.4%
Q4 FY2016Dec 31, 2016$10.27M–
Q3 FY2016Sep 30, 2016$7.75M–
Q2 FY2016Jun 30, 2016$5.42M–
Q1 FY2016Mar 31, 2016$5.59M–

More Soligenix figures

See a number that looks wrong?